Practice of Deep Venous Thrombosis Prophylaxis and Its Incidence in Patients Undergoing Gastrointestinal and Hepatobiliary Surgery

NCT ID: NCT07088575

Last Updated: 2025-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1530 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-23

Study Completion Date

2024-07-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recent studies from Asia have reported a wide variation in the incidence of deep vein thrombosis (DVT), ranging from 5% to 50% in patients undergoing major abdominal surgery. However, data specific to the Nepalese population remains unavailable. This study aims to evaluate current thromboprophylaxis practices and determine the incidence of DVT in Nepalese adults undergoing gastrointestinal and hepatobiliary surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients >18 years who underwent major gastrointestinal or hepatobiliary surgery

major gastrointestinal or hepatobiliary surgery under general anesthesia

Intervention Type PROCEDURE

major gastrointestinal or hepatobiliary surgery under general anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

major gastrointestinal or hepatobiliary surgery under general anesthesia

major gastrointestinal or hepatobiliary surgery under general anesthesia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged \>18 years
* Underwent major gastrointestinal or hepatobiliary surgery
* Surgery performed under general anesthesia
* Major surgery defined as any operative intervention in the abdominal or hepatobiliary region requiring general anesthesia

Exclusion Criteria

* History of VTE within 3 months before surgery
* Known hypercoagulable state or congenital thrombophilia
* Diagnosis of atrial fibrillation
* Undergoing systemic cancer chemotherapy or radiotherapy within the past 15 days
* Pregnant or lactating women
* Missing information in clinical records
* Non-operated patients or those receiving conservative management
* Patients undergoing liver transplantation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maharajgunj Medical Campus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prajjwol Luitel

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Prajjwol Luitel, MBBS

Role: PRINCIPAL_INVESTIGATOR

Maharajgunj Medical Campus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maharajgunj Medical Campus

Kathmandu, , Nepal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nepal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

589(6-11)E2.079/080

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Are Uterine Fibroids Pro-thrombotic?
NCT05607602 ACTIVE_NOT_RECRUITING